THE SCIENTIST–Former Head of UK Psychopharmacology says Money Didn’t Sway Dr. Nemeroff

A follow-up to news reports about the conflict of interest scandal that has engulfed not only Dr. Charles Nemeroff, former president and editor in chief of the official journal of the American College of Neuropsychopharmacology, but the College itself.
Continue reading →

FDA poised to change the health & wellbeing of all Americans

An illuminating essay by Byron Richards, author of Fight for Your Health: Exposing the FDA’s Betrayal of America,  should be required reading for every member of Congress before voting Yes or NO on the appointment of Dr. Andrew von Eschenbach, who is poised to head the FDA.

Continue reading →

ACNP Journal Editor Quits Amid Exposure of Conflicts of Interest

A notice  from The American College of Neuropsychopharmacology, the inner sanctum of biological–predominantly drug-centered psychiatry–informs the
membership of  the resignation of Dr. Charles Nemeroff, the Editor-in-Chief of its journal, Neuropsychopharmacology. 

Continue reading →

NYT Editorial: Safe Drug Testing in Prisons?

An editorial in today's New York Times is a follow-up to its riveting report by Ian Urbina on the recommendation by an Institute of Medicine panel to
lift 1978 federal restrictions on medical experiments on prisoners.
Continue reading →

FDA Strengthens Warnings on ADHD psychostimulant Drug Risks_NYT

The New York Times reports (below) that after months of foot dragging, the FDA has finally issued additional warnings on the labels of widely
prescribed psychostimulant drugs–Ritalin, Adderall, Concerta. Continue reading →